News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Glucon Medical Ltd. Announces Milestone Patent For Photoacoustic Assay And Imaging System For The Treatment Of Diabetes



10/19/2005 5:12:44 PM

BOULDER, Colo.--(BUSINESS WIRE)--Feb. 15, 2005--Glucon (www.glucon.com), developer of a continuous, noninvasive, glucose monitoring technology for home and clinical use, announced today the granting of U.S. Patent No. 6,846,288, issued on January 25, 2005 for the use of photoacoustic waves originating in a specific region (a blood vessel) to calculate the concentration of a component (glucose) in the blood vessel. The patent was granted to Glucon's founders, Company President Mr. Ron Nagar and V.P. of R&D, Dr. Benny Pesach.

Read at BioSpace.com


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES